Keyphrases
Hematological Malignancies
100%
Acute Promyelocytic Leukemia
100%
Arsenic Trioxide
100%
Clinical Investigator
50%
Relapse Rate
50%
Preclinical Data
50%
Combination Therapy
50%
Clinical Benefit
50%
In Vitro Data
50%
Reducing Agent
50%
Treatment Choice
50%
STI571
50%
Antineoplastic Agents
50%
Glutathione
50%
Anthracycline-based Chemotherapy
50%
Relapsed Patients
50%
Rare Subtype
50%
Multiple Mechanisms of Action
50%
Medicine and Dentistry
Acute Promyelocytic Leukemia
100%
In Vitro
100%
Hematologic Malignancy
100%
Arsenic Trioxide
100%
Combination Therapy
50%
Anthracycline
50%
Recurrence Risk
50%
Glutathione
50%
Reducing Agent
50%
Resuscitation
50%
Diseases
50%
Sexually Transmitted Infection
50%
Antineoplastic Agent
50%
Pharmacology, Toxicology and Pharmaceutical Science
Arsenous Acid
100%
Arsenite
100%
Hematologic Malignancy
100%
Promyelocytic Leukemia
100%
Chemotherapy
50%
Recurrence Risk
50%
Glutathione
50%
Reducing Agent
50%
Combination Therapy
50%
Anthracycline
50%
Diseases
50%
Antineoplastic Agent
50%